Article(id=1329527610696119020, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527576395100605, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.11.004, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1722528000000, receivedDateStr=2024-08-02, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794913683818, onlineDateStr=2026-11-17, pubDate=1731168000000, pubDateStr=2024-11-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794913683818, onlineIssueDateStr=2026-11-17, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794913683818, creator=13701087609, updateTime=1794913683818, updator=13701087609, issue=Issue{id=1329527576395100605, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='11', pageStart='1105', pageEnd='1211', issueExtLink='null', onlineDate='null', pubDate='1731168000000', pubDateStr='2024-11-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794913675640, creator='13701087609', updateTime=1794962226160, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329731212412825960, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527576395100605, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329731212412825961, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527576395100605, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1132, endPage=1140, ext={EN=ArticleExt(id=1329527610876474093, articleId=1329527610696119020, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Construction and optimization of the multi-level medical security system for rare disease drug, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=
Objectives

To evaluate the current situation of improvement of the affordability of rare disease drugs in China, and to provide recommendations for the construction and optimization of the multi-level medical security system for rare disease.

Methods

The reimbursement policies of outpatient chronic and special diseases, major medical expenses insurance, City Customized Commercial Health Insurance and medical assistance in 333 cities in China were collected, and the affordability of 5 National Reimbursement Drug List (NRDL) rare disease drugs with annual cost of more than 100 000 yuan and 6 non-NRDL drugs with annual cost of more than 900 000 yuan were evaluated by World Health Organization/Health Action International standard survey method.

Results

For the 6 high-value non-NRDL drugs only covered by the city customized commercial medical insurance (CCCMI), the payment years for these treatments was higher than 10 years, and the affordability was extremely poor. For 5 NRDL rare disease drugs, the affordability was poor (1.53—3.97 years) only under outpatient chronic and special disease coverage. When the major medical expenses insurance was articulated, teriflunomide (0.81 year) and recombinant human coagulation factor Ⅷ (0.91 year) were affordable, and the payment years of the other three drugs have a certain decrease. Following secondary reimbursement through CCCMI and third reimbursement through medical assistance, human coagulation factor Ⅷ(0.64 year) and miglustat (0.84 year) were also affordable. And there was a significant difference in the number of payment years after the multi-level medical security system.

Conclusion

Multi-level medical security system can effectively improve the affordability of medication for patients with rare diseases. In this regard, it is recommended that non-NRDL rare disease drugs should be included in NRDL as soon as possible, and the link of various levels of reimbursement should be strengthened.

, authors=Xinyang CHEN1, 2, Ye CHEN1, 2, Jinxi DING1, 2, *, authorsList=Xinyang CHEN, Ye CHEN, Jinxi DING, authorCompany=null, correspAuthors=Jinxi DING, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329527611132326639, articleId=1329527610696119020, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=罕见病用药多层次医疗保障体系的构建与优化, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=
目的

评估当前我国多层次保障体系对罕见病用药可负担性的改善情况,为罕见病用药多层次保障体系的构建和优化提供完善建议。

方法

收集我国333个地级行政区门诊慢特病、大病保险、惠民保和医疗救助的实际报销政策,并利用世界卫生组织/国际健康行动机构标准调查法对5种年费用超过10万元的医保目录内、6种年费用超过90万元的医保目录外罕见病用药进行可负担性评价。

结果

对于医保目录外罕见病用药,仅单一惠民保特药目录保障下支付年数均高于10年,可负担性极差。对于医保目录内罕见病用药,仅门诊慢特病保障下,可负担性均较差(1.53~3.97年)。当大病保险衔接后,特立氟胺(0.81年)与重组人凝血因子Ⅷ(0.91年)实现可负担,其余三种药品支付年数均有一定下降。当惠民保进行二次报销、医疗救助进行兜底保障后,人凝血因子Ⅷ(0.64年)和麦格司他(0.84年)也实现可负担,且每保障层次衔接后,支付年数均有显著性差异。

结论

多层次医疗保障体系能够有效改善罕见病患者的用药可负担性。对此,建议尽快纳入医保目录外超高值罕见病用药,并加强各保障层次间的待遇衔接。

, authors=陈昕阳1, 2, 陈烨1, 2, 丁锦希1, 2, *, authorsList=陈昕阳, 陈烨, 丁锦希, authorCompany=null, correspAuthors=丁锦希, authorNote=

陈昕阳,硕士研究生,研究方向:社会与管理药学。

, correspAuthorsNote=
丁锦希,二级教授、博士生导师,研究方向:医药政策法规、医药市场准入与药物经济学。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=QG1b0TgzlSMMzAZY3qVlEg==, magXml=IvVtQy65f3rrtn2jf1Aj4g==, pdfUrl=null, pdf=lx+DpFT0RT1KBcTOxlwTDQ==, pdfFileSize=1802862, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=evPj9qpwY7mkky1UID56gA==, mapNumber=null, fund=null)}, authors=[Author(id=1329532793366884791, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329532795002663354, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, authorId=1329532793366884791, language=EN, stringName=Xinyang CHEN, firstName=Xinyang, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329532795073966523, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, authorId=1329532793366884791, language=CN, stringName=陈昕阳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio={"content":"

陈昕阳,硕士研究生,研究方向:社会与管理药学。

"}, bioImg=null, bioContent=

陈昕阳,硕士研究生,研究方向:社会与管理药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329532793190724016, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, xref=1., ext=[AuthorCompanyExt(id=1329532793199112625, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793190724016, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532793211695538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793190724016, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1329532793278804403, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, xref=2., ext=[AuthorCompanyExt(id=1329532793291387316, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793278804403, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532793299775925, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793278804403, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])]), Author(id=1329532795157852605, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329532795220767168, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, authorId=1329532795157852605, language=EN, stringName=Ye CHEN, firstName=Ye, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329532795308847553, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, authorId=1329532795157852605, language=CN, stringName=陈烨, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329532793190724016, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, xref=1., ext=[AuthorCompanyExt(id=1329532793199112625, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793190724016, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532793211695538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793190724016, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1329532793278804403, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, xref=2., ext=[AuthorCompanyExt(id=1329532793291387316, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793278804403, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532793299775925, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793278804403, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])]), Author(id=1329532795375956419, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329532795438870982, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, authorId=1329532795375956419, language=EN, stringName=Jinxi DING, firstName=Jinxi, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329532795543728583, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, authorId=1329532795375956419, language=CN, stringName=丁锦希, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329532793190724016, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, xref=1., ext=[AuthorCompanyExt(id=1329532793199112625, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793190724016, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532793211695538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793190724016, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1329532793278804403, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, xref=2., ext=[AuthorCompanyExt(id=1329532793291387316, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793278804403, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532793299775925, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793278804403, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])])], keywords=[Keyword(id=1329532795766026696, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, language=EN, orderNo=1, keyword=rare disease drug), Keyword(id=1329532795828941257, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, language=EN, orderNo=2, keyword=multi-level medical security system), Keyword(id=1329532795896050122, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, language=EN, orderNo=3, keyword=affordability), Keyword(id=1329532795992519115, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, language=CN, orderNo=1, keyword=罕见病用药), Keyword(id=1329532796055433676, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, language=CN, orderNo=2, keyword=多层次医疗保障体系), Keyword(id=1329532796109959629, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, language=CN, orderNo=3, keyword=可负担性)], refs=[Reference(id=1329532796260954574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=詹洪春, 潘锋. 破解罕见病救治难题需统筹构建多层次保障机制[J]. 妇儿健康导刊, 2024, 3(7): 4-8., articleTitle=null, refAbstract=null), Reference(id=1329532796336452047, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=中国政府网. 关于深化医疗保障制度改革的意见[EB/OL]. (2020-03-05) [2024-05-31]. https://www.gov.cn/zhengce/2020-03/05/content_5487407.htm., articleTitle=null, refAbstract=null), Reference(id=1329532796424532432, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=朱楚玉, 孙维阳, 常峰, 等. 我国罕见病药品价格水平和可负担性研究[J]. 中国药房, 2021, 32(8): 897-903., articleTitle=null, refAbstract=null), Reference(id=1329532796500029905, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=李奕昊, 唐贵忠. 罕见病用药可负担性评价及医保政策研究[J]. 卫生经济研究, 2022, 39(4): 53-57., articleTitle=null, refAbstract=null), Reference(id=1329532796562944466, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=国家统计局. 2022年中国统计年鉴[M]. 北京: 中国统计出版社, 2023., articleTitle=null, refAbstract=null), Reference(id=1329532796634247635, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=艾昆玮. 中国罕见病高值药物医疗保障研究报告[R]. 上海: 艾昆玮., articleTitle=null, refAbstract=null), Reference(id=1329532796709745108, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=WHO/HAI. Measuringmedicineprices, availability, affordabil ityand price components[M]. 2nd ed. Geneva: World Health Organization, 2008: 5., articleTitle=null, refAbstract=null), Reference(id=1329532796785242581, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=信枭雄, 管晓东, 史录文. 基于5种罕见病可负担性评价的我国罕见病保障机制研究[J]. 中国药房, 2014, 25(5): 404-407., articleTitle=null, refAbstract=null), Reference(id=1329532796852351446, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=周盛明, 李嘉瑶, 周静, 等. 中国罕见病用药可负担性评价[J]. 中国药业, 2021, 30(1): 9-15., articleTitle=null, refAbstract=null), Reference(id=1329532796932043223, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=周婷婷, 潘杰. 不同保障水平下罕见病用药可负担性研究: 以脊髓性肌萎缩症为例[J]. 中国卫生经济, 2022, 41(2): 33-38., articleTitle=null, refAbstract=null), Reference(id=1329532797011735000, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=国家卫生健康委员会. 关于印发罕见病诊疗指南(2019年版)的通知[EB/OL]. (2019-02-27) [2024-06-05]. http://www.nhc.gov.cn/yzygj/s7659/201902/61d06b4916c348e0810ce1fceb844333.shtml., articleTitle=null, refAbstract=null), Reference(id=1329532797099815385, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=袁妮, 田婷婷, 张海军, 等. 英国罕见病用药纳入报销体系的主要途径及对我国的启示[J]. 中国药科大学学报, 2019, 50(1): 113-119., articleTitle=null, refAbstract=null), Reference(id=1329532797183701466, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=湖南省医疗保障局. 关于印发《湖南省城乡居民大病保险实施办法》的通知[EB/OL]. (2021-11-04) [2024-06-05]. https://ybj.hunan.gov.cn/ybj/first113541/firstF/f2113606/202111/t20211104_20976600.html., articleTitle=null, refAbstract=null), Reference(id=1329532797271781851, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=许闲. 坚持“更普惠”宗旨探索十大迭代方向《2023年城市定制型商业医疗保险(惠民保)知识图谱》解读[J]. 上海保险, 2023, (12): 12-18., articleTitle=null, refAbstract=null), Reference(id=1329532797343085020, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=中国政府网. 关于健全重特大疾病医疗保险和救助制度的意见[EB/OL]. (2021-11-19) [2024-06-19]. https://www.gov.cn/zhengce/content/2021-11/19/content_5651446.htm., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329532793190724016, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, xref=1., ext=[AuthorCompanyExt(id=1329532793199112625, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793190724016, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532793211695538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793190724016, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1329532793278804403, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, xref=2., ext=[AuthorCompanyExt(id=1329532793291387316, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793278804403, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532793299775925, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793278804403, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.11.004, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.11.004, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.11.004, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.11.004, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1731168000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
罕见病用药多层次医疗保障体系的构建与优化
陈昕阳 1, 2 , 陈烨 1, 2 , 丁锦希 1, 2, *
世界临床药物 | 医药专论 2024,45(11): 1132-1140
收起
收藏切换
世界临床药物 |医药专论 2024 , 45 (11) : 1132 -1140
罕见病用药多层次医疗保障体系的构建与优化
全屏
[Author(id=1329532793366884791, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329532795002663354, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, authorId=1329532793366884791, language=EN, stringName=Xinyang CHEN, firstName=Xinyang, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329532795073966523, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, authorId=1329532793366884791, language=CN, stringName=陈昕阳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio={"content":"

陈昕阳,硕士研究生,研究方向:社会与管理药学。

"}, bioImg=null, bioContent=

陈昕阳,硕士研究生,研究方向:社会与管理药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329532793190724016, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, xref=1., ext=[AuthorCompanyExt(id=1329532793199112625, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793190724016, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532793211695538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793190724016, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1329532793278804403, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, xref=2., ext=[AuthorCompanyExt(id=1329532793291387316, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793278804403, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532793299775925, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793278804403, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])]), Author(id=1329532795157852605, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329532795220767168, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, authorId=1329532795157852605, language=EN, stringName=Ye CHEN, firstName=Ye, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329532795308847553, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, authorId=1329532795157852605, language=CN, stringName=陈烨, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329532793190724016, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, xref=1., ext=[AuthorCompanyExt(id=1329532793199112625, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793190724016, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532793211695538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793190724016, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1329532793278804403, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, xref=2., ext=[AuthorCompanyExt(id=1329532793291387316, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793278804403, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532793299775925, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793278804403, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])]), Author(id=1329532795375956419, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329532795438870982, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, authorId=1329532795375956419, language=EN, stringName=Jinxi DING, firstName=Jinxi, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329532795543728583, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, authorId=1329532795375956419, language=CN, stringName=丁锦希, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329532793190724016, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, xref=1., ext=[AuthorCompanyExt(id=1329532793199112625, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793190724016, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532793211695538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793190724016, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1329532793278804403, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, xref=2., ext=[AuthorCompanyExt(id=1329532793291387316, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793278804403, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532793299775925, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527610696119020, companyId=1329532793278804403, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])])]
陈昕阳1, 2, 陈烨1, 2, 丁锦希1, 2, *
作者信息
  • 1.中国药科大学国际医药商学院,江苏 南京 211198
  • 2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198
通讯作者:
丁锦希,二级教授、博士生导师,研究方向:医药政策法规、医药市场准入与药物经济学。
作者简介:

陈昕阳,硕士研究生,研究方向:社会与管理药学。

Construction and optimization of the multi-level medical security system for rare disease drug
Xinyang CHEN1, 2, Ye CHEN1, 2, Jinxi DING1, 2, *
Affiliations
  • 1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
  • 2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
出版时间: 2024-11-10 doi: 10.13683/j.wph.2024.11.004
文章导航
收藏切换
目的

评估当前我国多层次保障体系对罕见病用药可负担性的改善情况,为罕见病用药多层次保障体系的构建和优化提供完善建议。

方法

收集我国333个地级行政区门诊慢特病、大病保险、惠民保和医疗救助的实际报销政策,并利用世界卫生组织/国际健康行动机构标准调查法对5种年费用超过10万元的医保目录内、6种年费用超过90万元的医保目录外罕见病用药进行可负担性评价。

结果

对于医保目录外罕见病用药,仅单一惠民保特药目录保障下支付年数均高于10年,可负担性极差。对于医保目录内罕见病用药,仅门诊慢特病保障下,可负担性均较差(1.53~3.97年)。当大病保险衔接后,特立氟胺(0.81年)与重组人凝血因子Ⅷ(0.91年)实现可负担,其余三种药品支付年数均有一定下降。当惠民保进行二次报销、医疗救助进行兜底保障后,人凝血因子Ⅷ(0.64年)和麦格司他(0.84年)也实现可负担,且每保障层次衔接后,支付年数均有显著性差异。

结论

多层次医疗保障体系能够有效改善罕见病患者的用药可负担性。对此,建议尽快纳入医保目录外超高值罕见病用药,并加强各保障层次间的待遇衔接。

罕见病用药  /  多层次医疗保障体系  /  可负担性
Objectives

To evaluate the current situation of improvement of the affordability of rare disease drugs in China, and to provide recommendations for the construction and optimization of the multi-level medical security system for rare disease.

Methods

The reimbursement policies of outpatient chronic and special diseases, major medical expenses insurance, City Customized Commercial Health Insurance and medical assistance in 333 cities in China were collected, and the affordability of 5 National Reimbursement Drug List (NRDL) rare disease drugs with annual cost of more than 100 000 yuan and 6 non-NRDL drugs with annual cost of more than 900 000 yuan were evaluated by World Health Organization/Health Action International standard survey method.

Results

For the 6 high-value non-NRDL drugs only covered by the city customized commercial medical insurance (CCCMI), the payment years for these treatments was higher than 10 years, and the affordability was extremely poor. For 5 NRDL rare disease drugs, the affordability was poor (1.53—3.97 years) only under outpatient chronic and special disease coverage. When the major medical expenses insurance was articulated, teriflunomide (0.81 year) and recombinant human coagulation factor Ⅷ (0.91 year) were affordable, and the payment years of the other three drugs have a certain decrease. Following secondary reimbursement through CCCMI and third reimbursement through medical assistance, human coagulation factor Ⅷ(0.64 year) and miglustat (0.84 year) were also affordable. And there was a significant difference in the number of payment years after the multi-level medical security system.

Conclusion

Multi-level medical security system can effectively improve the affordability of medication for patients with rare diseases. In this regard, it is recommended that non-NRDL rare disease drugs should be included in NRDL as soon as possible, and the link of various levels of reimbursement should be strengthened.

rare disease drug  /  multi-level medical security system  /  affordability
陈昕阳, 陈烨, 丁锦希. 罕见病用药多层次医疗保障体系的构建与优化. 世界临床药物, 2024 , 45 (11) : 1132 -1140 . DOI: 10.13683/j.wph.2024.11.004
Xinyang CHEN, Ye CHEN, Jinxi DING. Construction and optimization of the multi-level medical security system for rare disease drug[J]. World Clinical Drug, 2024 , 45 (11) : 1132 -1140 . DOI: 10.13683/j.wph.2024.11.004

参考文献 引证文献
排序方式:
[1]
詹洪春, 潘锋. 破解罕见病救治难题需统筹构建多层次保障机制[J]. 妇儿健康导刊, 2024, 3(7): 4-8.
[2]
中国政府网. 关于深化医疗保障制度改革的意见[EB/OL]. (2020-03-05) [2024-05-31]. https://www.gov.cn/zhengce/2020-03/05/content_5487407.htm.
[3]
朱楚玉, 孙维阳, 常峰, 等. 我国罕见病药品价格水平和可负担性研究[J]. 中国药房, 2021, 32(8): 897-903.
[4]
李奕昊, 唐贵忠. 罕见病用药可负担性评价及医保政策研究[J]. 卫生经济研究, 2022, 39(4): 53-57.
[5]
国家统计局. 2022年中国统计年鉴[M]. 北京: 中国统计出版社, 2023.
[6]
艾昆玮. 中国罕见病高值药物医疗保障研究报告[R]. 上海: 艾昆玮.
[7]
WHO/HAI. Measuringmedicineprices, availability, affordabil ityand price components[M]. 2nd ed. Geneva: World Health Organization, 2008: 5.
[8]
信枭雄, 管晓东, 史录文. 基于5种罕见病可负担性评价的我国罕见病保障机制研究[J]. 中国药房, 2014, 25(5): 404-407.
[9]
周盛明, 李嘉瑶, 周静, 等. 中国罕见病用药可负担性评价[J]. 中国药业, 2021, 30(1): 9-15.
[10]
周婷婷, 潘杰. 不同保障水平下罕见病用药可负担性研究: 以脊髓性肌萎缩症为例[J]. 中国卫生经济, 2022, 41(2): 33-38.
[11]
国家卫生健康委员会. 关于印发罕见病诊疗指南(2019年版)的通知[EB/OL]. (2019-02-27) [2024-06-05]. http://www.nhc.gov.cn/yzygj/s7659/201902/61d06b4916c348e0810ce1fceb844333.shtml.
[12]
袁妮, 田婷婷, 张海军, 等. 英国罕见病用药纳入报销体系的主要途径及对我国的启示[J]. 中国药科大学学报, 2019, 50(1): 113-119.
[13]
湖南省医疗保障局. 关于印发《湖南省城乡居民大病保险实施办法》的通知[EB/OL]. (2021-11-04) [2024-06-05]. https://ybj.hunan.gov.cn/ybj/first113541/firstF/f2113606/202111/t20211104_20976600.html.
[14]
许闲. 坚持“更普惠”宗旨探索十大迭代方向《2023年城市定制型商业医疗保险(惠民保)知识图谱》解读[J]. 上海保险, 2023, (12): 12-18.
[15]
中国政府网. 关于健全重特大疾病医疗保险和救助制度的意见[EB/OL]. (2021-11-19) [2024-06-19]. https://www.gov.cn/zhengce/content/2021-11/19/content_5651446.htm.
2024年第45卷第11期
16
2
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.11.004
  • 接收时间:2024-08-02
  • 首发时间:2026-11-17
  • 出版时间:2024-11-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-08-02
基金
作者信息
    1.中国药科大学国际医药商学院,江苏 南京 211198
    2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198

通讯作者:

丁锦希,二级教授、博士生导师,研究方向:医药政策法规、医药市场准入与药物经济学。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.11.004
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏